Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.246x

Based on the latest financial reports, Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a cash flow conversion efficiency ratio of 0.246x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥281.88 Million ≈ $41.25 Million USD) by net assets (CN¥1.15 Billion ≈ $167.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Shaanxi Meibang Pharmaceutical Group Co for the company's overall valuation and market capitalisation.

Shaanxi Meibang Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Shaanxi Meibang Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shaanxi Meibang Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Meibang Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore 605033 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Chemclin Diagnostics Co. Ltd. A SHG:688468	0.024x
Lingsen Precision Industries Ltd TW:2369	-0.013x
D-Link Corp TW:2332	-0.022x
G. Willi-Food International Ltd. NASDAQ:WILCF	0.024x
Liaoning He Eye Hospital Group Co. LTD. SHE:301103	N/A
KNOT Offshore Partners LP NYSE:KNOP	0.054x
CASIN Real Estate Development Group Co Ltd SHE:000838	0.079x
EGing Photovoltaic Technology Co Ltd SHG:600537	-0.135x

Annual Cash Flow Conversion Efficiency for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024. View current stock price of Shaanxi Meibang Pharmaceutical Group Co for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.12 Billion ≈ $164.57 Million	CN¥280.40 Million ≈ $41.03 Million	0.249x	-17.03%
2023-12-31	CN¥1.11 Billion ≈ $163.04 Million	CN¥334.79 Million ≈ $48.99 Million	0.300x	+158.23%
2022-12-31	CN¥1.09 Billion ≈ $158.97 Million	CN¥126.41 Million ≈ $18.50 Million	0.116x	+203.46%
2021-12-31	CN¥966.95 Million ≈ $141.50 Million	CN¥-108.75 Million ≈ $-15.91 Million	-0.112x	-167.50%
2020-12-31	CN¥449.37 Million ≈ $65.76 Million	CN¥74.88 Million ≈ $10.96 Million	0.167x	-51.92%
2019-12-31	CN¥370.63 Million ≈ $54.24 Million	CN¥128.45 Million ≈ $18.80 Million	0.347x	+464.79%
2018-12-31	CN¥276.37 Million ≈ $40.44 Million	CN¥16.96 Million ≈ $2.48 Million	0.061x	-62.35%
2017-12-31	CN¥180.43 Million ≈ $26.40 Million	CN¥29.41 Million ≈ $4.30 Million	0.163x	--

About Shaanxi Meibang Pharmaceutical Group Co Ltd

SHG:605033 China Agricultural Inputs

Market Cap

$365.61 Million

CN¥2.50 Billion CNY

Market Cap Rank

#13993 Global

#4191 in China

Share Price

CN¥18.48

Change (1 day)

-0.16%

52-Week Range

CN¥16.11 - CN¥31.54

All Time High

CN¥31.54